Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Combination Therapy for Extreme Drug–Resistant Acinetobacter baumannii

Ready for Prime Time?*

Spellberg, Brad MD; Bonomo, Robert A. MD

doi: 10.1097/CCM.0000000000001029

Division of Infectious Diseases, Keck School of Medicine at USC and the Los Angeles County-USC Medical Center, Los Angeles, CA

Department of Medicine, Department of Pharmacology, Department of Molecular Biology and Microbiology, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Case Western Reserve University, Cleveland, OH

* See also p. 1194.

Dr. Spellberg has received support for article research from the National Institutes of Health (NIH). His institution received grant support from the NIH (Dr. Spellberg is a funded investigator who does research on Acinetobacter). Dr. Bonomo has received support for article research from the NIH.

Copyright © by 2015 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.